Application of DDX20 in preparation of rectal cancer postoperative prognosis evaluation kit
A DDX20, 1. DDX20 technology is applied in the application field of DDX20 in the preparation of rectal cancer postoperative prognosis evaluation kits, which can solve the problems of lack of specific molecular targets and unclear molecular mechanisms for treatment.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] (a) Pathological specimens were obtained from biopsies or intraoperative and postoperative pathological materials of rectal cancer patients.
[0042] (b) The immunohistochemical method uses the SP staining method, and the specific steps are as follows:
[0043] (c) Paraffin sections of rectal cancer tissues were prepared, and the oven was set at 60° C. overnight.
[0044] (d) Dewaxing of slices. Soak in sequence: Xylene I: 10min; Xylene II: 10min; Xylene III: 10min.
[0045] (e) Section hydration. Soak in sequence: absolute ethanol: 3 min; 90% (v / v) ethanol: 3 min; 80% ethanol: 3 min; 75% ethanol: 3 min.
[0046] (f) Washing with PBS 3 times, 5 min each time.
[0047](h) EDTA antigen high-pressure repair: soak the slices in 0.01M EDTA repair solution, soak in boiling water for 5 minutes, and cool to room temperature. Wash with PBS 3 times, 5min each time.
[0048] (I) Add 300 μL of 3% (w / w) hydrogen peroxide aqueous solution, 37° C. for 10 min. Wash with PBS 3 ti...
Embodiment 2
[0063] A postoperative tumor sample of rectal cancer was taken for paraffin-embedded section, and detected by the above-mentioned immunohistochemical method. After calculation, the DDX20 immunohistochemical score of the cancer tissue was 0.621. After postoperative follow-up, it was found that the patient had recurrence and metastasis of rectal cancer in the 35th month after the operation, and died 46 months after the operation.
Embodiment 3
[0065] A postoperative tumor sample of rectal cancer was taken for paraffin-embedded section, and the above-mentioned immunohistochemical method was used for detection. After calculation, the DDX20 immunohistochemical score of the cancer tissue was 0.399. After postoperative follow-up, it was found that the patient was alive without metastasis and recurrence 5 years after the operation.
[0066] From the above test results, it can be known that detecting the relative expression of DDX20 molecules by immunohistochemical method can predict the risk of distant metastasis of rectal cancer and the postoperative survival or death of patients. When the DDX20 immunohistochemical score of cancer tissue is higher than 0.532, rectal cancer is prone to recurrence and metastasis, and rectal cancer patients are likely to die after surgery. Obviously, DDX20 is related to rectal cancer. Therefore, using DDX20 as a protein molecular marker to detect its expression level can predict recurrence ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com